The Huber Needle Market is ascertained to make greater strides in the future. The present-day and futuristic cutting-edge technology, namely IoT, AI, and Big Data operate better in a lightning-fast and reliable internet connection. The benefits of high-speed internet would be seen in telecare in the next 2-3 years, but going forward, more authentic data streams are likely to come up with better-connected devices, thereby revolutionizing the healthcare system.
Manufacturers are also increasingly investing in the research and development of new products ensuring safety and easy-to-use features. New production and testing methods are also being adapted to meet the increasing demand and testing to avoid any adverse health effects due to Huber needles. The Food and Drug Administration (FDA) has also introduced an anti-coring test for Huber needles. However, Huber needles are costly as compared to traditional needles and the risk of infection through Huber needles are likely to hamper the growth of the global Huber needles market.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3291
The global market for Huber needles is expected to witness significant growth during 2017-2024, according to the report by Persistence Market Research. By the end of 2024, the global Huber needles market is projected to bring in more than US$ 50 Million revenue.
Company Profiles:
- Baxter International Inc
- C. R. Bard, Inc
- NIPRO Medical Corporation
- B. Braun Medical Inc.
- Smiths Medical
- Exel International, Inc.
- Vygon S.A.
- AngioDynamics, Inc.
- Thiebaud S.A.S.
- Others
Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com
Curved Huber Needles to Witness Robust Growth During the Forecast Period 2017-2024
Based on the product type, compared to the straight Huber needles, curved Huber needles are likely to see substantial growth. Curved Huber needles are estimated to exceed US$ 40 Million revenue by 2024 end.
On the basis of application, Huber needles are expected to find large application in IV cancer. Towards 2024 end, Huber needles application for IV cancer is projected to surpass US$ 20 Million revenue. Meanwhile, application of Huber needles in dialysis is also expected to significantly grow in the next few years.
By end user, hospitals followed by oncology centers are likely to be the largest users of Huber needles in the global Huber needles market. Hospitals as a user of Huber needles are projected to bring in more than US$ 20 Million revenue.
North America to Lead the Global Market for Huber Needles Between 2017 and 2024
The U.S. is likely to emerge as the largest country in the Huber needles market in North America. The region is witnessing an increasing adoption of Huber needles for long-term drug infusion. The diagnoses rate in the region has also increased in the region in recent years, this is also creating demand for Huber needles in North America. Meanwhile, in Europe, Germany, Italy, and France hold maximum share in the Huber needles market. However, increasing awareness about the treatment of cancer in the Asia Pacific is also likely to drive the demand for Huber needles in the region.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/3291
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com